KRAS G12C inhibitors in KRASG12C-mutated solid tumors: an immunologically informed systematic review and reconstructed individual patient data meta-analysis - Quiz - MDSpire

KRAS G12C inhibitors in KRASG12C-mutated solid tumors: an immunologically informed systematic review and reconstructed individual patient data meta-analysis

  • By

  • Yici Yan

  • Leyi Zheng

  • Hongfei Wang

  • Leitao Sun

  • Xing Xu

  • July 10, 2026

  • 0 min

Share

Original Source(s)

KRAS G12C inhibitors in KRASG12C-mutated solid tumors: an immunologically informed systematic review and reconstructed individual patient data meta-analysis

  • by Yici Yan, Leyi Zheng, Hongfei Wang, Leitao Sun, Xing Xu

  • July 10, 2026

Related Content

Inside the Rise of circRNA

Circio CEO Erik Wiklund reflects on the discovery of human circular RNA and its evolution into a fast-moving therapeutic modality

  • July 9, 2026

  • 12 min
An integrative naturopathic oncology approach in metastatic malignant melanoma: two case reports

Clinical features and treatment challenges of HER2-positive primary breast squamous cell carcinoma: a case report and literature review